"Paws for the Cure" - Friends of Mary Louise Pawlowski

This shirt was designed by Mr. Knickerbocker to support Mary-Louise Pawlowski, daughter of former pitcher and Clemson Baseball coach John Pawlowski. Five dollars of every shirt sold goes directly to help offset the cost of her treatment.

Go to the Mr. Knickerbocker site to order a shirt: http://www.mrknickerbocker.com/pc-625-18-paws-for-the-cure.aspx

What makes Mr. Knickerbocker unique is its dedication to Clemson as 100% of our merchandise is licensed Clemson products. With its total focus on Clemson University, Mr. Knickerbocker has a national reputation with Tiger fans, and the success of this unique philosophy has earned us the respect of manufacturers and other retailers.
"A Clemson Tradition for over Twenty Five Years."
The College of Charleston Baseball team plays at Clemson on Tuesday May 13, 2008 at 7:15pm

13 year old Mary-Louise Pawlowiski of North Augusta has been diagnosed with PNET (primitive neuroectodermal tumors), a rare malignancy seen in only two percent of children with cancer. X-rays showed a spot on her lung. They thought it might be pneumonia, but by mid-December the spot had doubled in size. Five days before Christmas, the doctors delivered the diagnosis.

The State reports: Smoking ban in Columbia bars possible

Complaints prompt Cromartie to consider law covering all workplaces
By ADAM BEAM - abeam@thestate.com

A deal might be in the works that would ban smoking in all Columbia workplaces — including bars.
Councilman E.W. Cromartie, one of the four council members who voted to exempt bars from the city’s smoking ban, is having second thoughts about the issue.
“I think we may have to look at that again,” Cromartie said. “It has been some time since the last time we voted.”
Only one council member would have to change his or her vote for the issue to be reconsidered.
The change comes after hearing complaints from restaurant and bar owners.
Andy Yogherty, owner of the Publick House on Devine Street, pleaded with council members earlier this week to change their minds. He said excluding bars penalizes businesses, like his, that have both a restaurant and a bar.
If there is to be a smoking ban, he said, it should be enforced across the board. Yogherty apparently struck a chord with Cromartie.

Mouth Test Could Predict Lung Cancer

Reuters Posted: 2008-04-14 09:56:02

WASHINGTON (April 13) - Damage to cells lining the mouth can predict similar damage in the lungs that eventually leads to lung cancer in smokers, U.S. researchers reported on Sunday.They hope it may be possible to some day swab the mouths of smokers to predict who is developing lung cancer -- saving painful and dangerous biopsies of the lung.The process may also lead to tests that will predict other cancers, said Dr. Li Mao, an expert in head, neck and lung cancer at the University of Texas M.D. Anderson Cancer Center in Houston.

The Island Packet of Hilton Head reports: God, family and golf: How Charles Perry defeated lung cancer

By: David Lauderdale

When the Verizon Heritage rolled around last year, the rumbling voice of Charles Perry was silent. For the first time in 21 years, Perry was not there in his knickers, red coat and straw hat, announcing each player as he approached the 9th green.
A year ago, Perry had just been hit by news that makes the chase for a little white ball seem trivial. He had been told he had lung cancer...He's been through lung surgery, chemotherapy and radiation. He's battled depression, low white blood cell counts, a violent reaction to chemotherapy that almost killed him, dizziness, a brain scan, loss of hearing, loss of energy, steroids, an endoscopy, a colonoscopy, hallucinations, anxiety attacks and enough side effects to fill a book of small print.
But he didn't lose his hair, his humor, his voice -- or his hope.

WIS News 10 of the midlands reports: High-Dose Chemo Fails Against Small Cell Lung Cancers

WEDNESDAY, April 9 (HealthDay News) -- High-intensity chemotherapy does not improve the survival rate of patients with small cell lung cancer (SCLC), a new Swiss study concludes.
Testing on 140 patients in a randomized trial showed no statistically significant differences in survival rate or tumor size between groups receiving either standard or high doses of chemo over a three-year period. The findings were published online April 8 in the Journal of the National Cancer Institute.

-- Kevin McKeever
SOURCE: Journal of the National Cancer Institute, news release, April 8, 2008